Health Catalyst Capital

Health Catalyst Capital Management is a New York-based venture capital firm established in 2015, specializing in investments in high-growth healthcare technology companies in the United States. The firm focuses on key themes within the healthcare IT sector, including personalized medicine, patient navigation, and hospital workflow automation, with the aim of identifying businesses that have the potential to achieve a billion-dollar enterprise value in emerging or disrupted markets. Health Catalyst typically seeks to exit its investments through initial public offerings or by selling to strategic acquirers and crossover fund investors.

Charles Boorady

Founder and Managing Partner

Bryan J. Carey

Operating Partner

Nico Holtz

Senior Associate

Vienn Kim

Associate

Daniel Ross

Partner

34 past transactions

Pager

Series C in 2021
Pager, Inc. develops and operates an on-demand service platform that connects patients with healthcare in their home, office, and hotel. The company offers Pager, a location-based mobile application that connects users with care to treat their urgent care needs, including urinary tract infection, upper respiratory infection, strep throat, fever, bronchitis, influenza, cold, nausea, back pain, rashes, burns, allergy, asthma, and others. It also provides nurse chat, teleconsult, screening, vaccination, and prescription delivery services. The company was formerly known as techCare, Inc. and changed its name to Pager, Inc. in July, 2014. Pager, Inc. was incorporated in 2013 and is based in New York, New York.

PierianDx

Venture Round in 2021
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.

ReferWell

Private Equity Round in 2016
ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently. With our system, you’ll direct patients toward the highest-quality providers, increase patient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities.

Medal

Venture Round in 2019
Medal, Inc. operates in the healthcare industry that offers administrator services. The company was incorporated in 2015 and is based in San Francisco, California. As of July 28, 2020, Medal, Inc. operates as a subsidiary of CIOX Health.

Glooko

Series D in 2021
Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.

Insightin Health

Series A in 2021
Insightin Health develops a platform that automates recommendations for preventative care for patients within healthcare systems. The company’s cloud-based convergent marketing platform allows healthcare organizations to develop a data hub for all channels both internal and external sources and allows data aggregation. The platform offers campaign automation which allows clients to create personalized and rule based content delivery in real-time; data management; and predictive approach from the dashboard which provides real-time actionable analytics. It centralizes member activities and delivers automated and personalized preventative actions for their healthcare journey. Additionally, the AI driven platform allows health plans to gain quality membership and lower churn by improving satisfaction and renewals. It serves Medicare/Medicaid, ACO, and FMO/broker/agent markets. The company was founded in 2016 and is headquartered in Gaithersburg, Maryland with an additional office in Pittsburgh, Pennsylvania.

PierianDx

Series A in 2016
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.

Risalto Health

Private Placement in 2018
Risalto Health Inc. designs and develops a platform that connects patients, care providers, and concierges using big data. It Risalto to identify the health care providers and integrate them into a white glove concierge model, delivering musculoskeletal care for all patients. The company’s Risalto uses analytics platform to assemble a team of doctors, physical therapists, chiropractors, and surgeons for back, neck, knee, and hip pain. The company was incorporated in 2016 and is based in New York, New York.

Insightin Health

Seed Round in 2019
Insightin Health develops a platform that automates recommendations for preventative care for patients within healthcare systems. The company’s cloud-based convergent marketing platform allows healthcare organizations to develop a data hub for all channels both internal and external sources and allows data aggregation. The platform offers campaign automation which allows clients to create personalized and rule based content delivery in real-time; data management; and predictive approach from the dashboard which provides real-time actionable analytics. It centralizes member activities and delivers automated and personalized preventative actions for their healthcare journey. Additionally, the AI driven platform allows health plans to gain quality membership and lower churn by improving satisfaction and renewals. It serves Medicare/Medicaid, ACO, and FMO/broker/agent markets. The company was founded in 2016 and is headquartered in Gaithersburg, Maryland with an additional office in Pittsburgh, Pennsylvania.

Pager

Private Placement in 2020
Pager, Inc. develops and operates an on-demand service platform that connects patients with healthcare in their home, office, and hotel. The company offers Pager, a location-based mobile application that connects users with care to treat their urgent care needs, including urinary tract infection, upper respiratory infection, strep throat, fever, bronchitis, influenza, cold, nausea, back pain, rashes, burns, allergy, asthma, and others. It also provides nurse chat, teleconsult, screening, vaccination, and prescription delivery services. The company was formerly known as techCare, Inc. and changed its name to Pager, Inc. in July, 2014. Pager, Inc. was incorporated in 2013 and is based in New York, New York.

Urgent Consult, Inc.

Private Placement in 2020
Urgent Consult, Inc. provides a cloud-based referral automation platform that streamlines the referral process. It offers ReferWell, a cloud-based referral automation solution that empowers primary doctors to schedule patient visits with the right doctors; and share clinical information across various electronic medical record systems. The company serves providers, patients, and payers. Urgent Consult, Inc. was incorporated in 2015 and is based in Stamford, New York.

PierianDx

Series B in 2019
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.

Insightin Health

Seed Round in 2018
Insightin Health develops a platform that automates recommendations for preventative care for patients within healthcare systems. The company’s cloud-based convergent marketing platform allows healthcare organizations to develop a data hub for all channels both internal and external sources and allows data aggregation. The platform offers campaign automation which allows clients to create personalized and rule based content delivery in real-time; data management; and predictive approach from the dashboard which provides real-time actionable analytics. It centralizes member activities and delivers automated and personalized preventative actions for their healthcare journey. Additionally, the AI driven platform allows health plans to gain quality membership and lower churn by improving satisfaction and renewals. It serves Medicare/Medicaid, ACO, and FMO/broker/agent markets. The company was founded in 2016 and is headquartered in Gaithersburg, Maryland with an additional office in Pittsburgh, Pennsylvania.

Holmusk

Series B in 2023
Holmusk is a global digital health and data analytics company, focused on solving complex problems in healthcare for chronic diseases. It builds innovative, scalable and cost-effective digital behaviour change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health. It develops powerful predictive algorithms that offer actionable insights for personalised care and population health management. Holmusk was founded in 2015 and is based in Singapore, Malaysia and USA.

ReferWell

Series B in 2023
ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently. With our system, you’ll direct patients toward the highest-quality providers, increase patient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities.

Clearsense

Series D in 2023
Clearsense is a data platform for healthcare that enables real-time insights into clinical, operational, and financial metrics. Its platform converts data into a single source of truth to accelerate data maturity, optimize analytics tools, improve decision quality, and unlock meaningful outcomes.

Cylinder

Series B in 2023
Vivante Health, Inc., a digital health company, develops solutions to manage chronic conditions. It offers GIThrive, a technology platform that provides actionable insights to members manage their digestive conditions, as well as empowers people through technology, advanced science, and on-demand human support for cost savings for health plans and self-insured employers. The company’s GIThrive also acts as a digital gut health program that provides expert insights and guidance, monitoring and analysis, and 24/7 gut-side assistance. In addition, it offers GIMate, a portable breathalyzer that identifies trigger food; and GutCheck, an at-home microbiome analysis of gut bacteria that provides a personalized diet, recommendations, and care plans. Vivante Health, Inc. was incorporated in 2015 and is based in Houston, Texas with an additional office in Athens, Greece.

Risalto Health

Series A in 2019
Risalto Health Inc. designs and develops a platform that connects patients, care providers, and concierges using big data. It Risalto to identify the health care providers and integrate them into a white glove concierge model, delivering musculoskeletal care for all patients. The company’s Risalto uses analytics platform to assemble a team of doctors, physical therapists, chiropractors, and surgeons for back, neck, knee, and hip pain. The company was incorporated in 2016 and is based in New York, New York.

PierianDx

Private Placement in 2019
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.

Simplifeye

Venture Round in 2019
Simplifeye provides SaaS platform for medical offices that connects wearables, like the Apple Watch, to existing health record software. - Provides a modern interface on wearable technology. - Allows providers to see a high-level view of every patient in their practice that is ready to be seen. - Displays medical alerts and overview of appointment details.

Cardiogram

Venture Round in 2018
Cardiogram lets you analyze and graph heart rate measurements from the Health app (requires a device with a heart rate monitor). With Cardiogram you can see how your heart reacts during an intense workout, track changes to your resting heart rate, track spikes to your heart rate elated to stress, diet or exercise. Users can also share graphs of their heart rate via email, Twitter or Facebook. Cardiogram is used for apple watch and android wear.

Holmusk

Series A in 2020
Holmusk is a global digital health and data analytics company, focused on solving complex problems in healthcare for chronic diseases. It builds innovative, scalable and cost-effective digital behaviour change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health. It develops powerful predictive algorithms that offer actionable insights for personalised care and population health management. Holmusk was founded in 2015 and is based in Singapore, Malaysia and USA.

Clearsense

Venture Round in 2021
Clearsense is a data platform for healthcare that enables real-time insights into clinical, operational, and financial metrics. Its platform converts data into a single source of truth to accelerate data maturity, optimize analytics tools, improve decision quality, and unlock meaningful outcomes.

Holmusk

Venture Round in 2021
Holmusk is a global digital health and data analytics company, focused on solving complex problems in healthcare for chronic diseases. It builds innovative, scalable and cost-effective digital behaviour change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health. It develops powerful predictive algorithms that offer actionable insights for personalised care and population health management. Holmusk was founded in 2015 and is based in Singapore, Malaysia and USA.

Click Therapeutics

Series B in 2021
Click Therapeutics, Inc. engineers, validates, develops, and commercializes digital therapeutics solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. It develops and commercializes novel digital therapeutics for various indications, including smoking cessation, major depressive disorders, schizophrenia, insomnia, acute coronary syndrome, migraine, overactive bladder, chronic low back pain, and obesity. Click Therapeutics, Inc. was founded in 2012 and is based in New York, New York.

Pager

Series B in 2020
Pager, Inc. develops and operates an on-demand service platform that connects patients with healthcare in their home, office, and hotel. The company offers Pager, a location-based mobile application that connects users with care to treat their urgent care needs, including urinary tract infection, upper respiratory infection, strep throat, fever, bronchitis, influenza, cold, nausea, back pain, rashes, burns, allergy, asthma, and others. It also provides nurse chat, teleconsult, screening, vaccination, and prescription delivery services. The company was formerly known as techCare, Inc. and changed its name to Pager, Inc. in July, 2014. Pager, Inc. was incorporated in 2013 and is based in New York, New York.

Risalto Health

Seed Round in 2018
Risalto Health Inc. designs and develops a platform that connects patients, care providers, and concierges using big data. It Risalto to identify the health care providers and integrate them into a white glove concierge model, delivering musculoskeletal care for all patients. The company’s Risalto uses analytics platform to assemble a team of doctors, physical therapists, chiropractors, and surgeons for back, neck, knee, and hip pain. The company was incorporated in 2016 and is based in New York, New York.

Insightin Health

Private Placement in 2018
Insightin Health develops a platform that automates recommendations for preventative care for patients within healthcare systems. The company’s cloud-based convergent marketing platform allows healthcare organizations to develop a data hub for all channels both internal and external sources and allows data aggregation. The platform offers campaign automation which allows clients to create personalized and rule based content delivery in real-time; data management; and predictive approach from the dashboard which provides real-time actionable analytics. It centralizes member activities and delivers automated and personalized preventative actions for their healthcare journey. Additionally, the AI driven platform allows health plans to gain quality membership and lower churn by improving satisfaction and renewals. It serves Medicare/Medicaid, ACO, and FMO/broker/agent markets. The company was founded in 2016 and is headquartered in Gaithersburg, Maryland with an additional office in Pittsburgh, Pennsylvania.

Holmusk

Private Placement in 2020
Holmusk is a global digital health and data analytics company, focused on solving complex problems in healthcare for chronic diseases. It builds innovative, scalable and cost-effective digital behaviour change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health. It develops powerful predictive algorithms that offer actionable insights for personalised care and population health management. Holmusk was founded in 2015 and is based in Singapore, Malaysia and USA.

Risalto Health

Private Placement in 2019
Risalto Health Inc. designs and develops a platform that connects patients, care providers, and concierges using big data. It Risalto to identify the health care providers and integrate them into a white glove concierge model, delivering musculoskeletal care for all patients. The company’s Risalto uses analytics platform to assemble a team of doctors, physical therapists, chiropractors, and surgeons for back, neck, knee, and hip pain. The company was incorporated in 2016 and is based in New York, New York.

ReferWell

Venture Round in 2020
ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently. With our system, you’ll direct patients toward the highest-quality providers, increase patient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities.